Hemlibra_mag.png

Hemlibra

Roche®

HEMLIBRA® is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children with hemophilia A with or without factor VIII inhibitors.

This bold, flexible graphic campaign highlights the unique MoA that mimics Factor VIII (F8) inhibitors, appealing to a very pragmatic scientific audience of experts who are attracted by efficacy and data rather than emotive imagery, separating Hemlibra even more from its competitors.

hemi_02.png
hemi_03.png
hemi_video_library.png

Additional  materials included an online depository of videos from both HCPs and patient testimonials for a CRM platform and
a chatbot app acting as an innovative objection handler tool.

hemi_bespoke.png
hemi-Chatbot.png
hemlibra_optionB.jpg
hemlibra_optionA.jpg

Alternative creative options presented at pitch stage

(click to enlarge)